Literature DB >> 1803050

A case of pyrazinamide-associated myoglobinuric renal failure.

S Namba1, T Igari, K Nishiyama, K Hashimoto, T Takemura, K Kimura.   

Abstract

A 50-year-old man developed myoglobinuric renal failure after taking pyrazinamide. Both serum and urine myoglobin levels were elevated and tubulo-interstitial nephropathy was demonstrated on renal biopsy. After pyrazinamide was discontinued, the myoglobin concentrations were normalized and his renal function ameliorated. The rhabdomyolysis was considered to be caused by pyrazinamide. To our knowledge, this is the first reported case of rhabdomyolysis associated with pyrazinamide.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1803050     DOI: 10.2169/internalmedicine1962.30.468

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  2 in total

1.  Drug-induced myopathy in a patient with pulmonary tuberculosis.

Authors:  Rajiv Shah; Pradhib Venkatesan
Journal:  BMJ Case Rep       Date:  2015-07-15

2.  Safety of Pyrazinamide for the Treatment of Tuberculosis in Older Patients Over 75 Years of Age: A Retrospective Monocentric Cohort Study.

Authors:  Stella Rousset; Margaux Lafaurie; Hélène Guet-Revillet; Caroline Protin; Jean Le Grusse; Hélène Derumeaux; Peggy Gandia; Fatemeh Nourhashemi; Laurent Sailler; Agnès Sommet; Pierre Delobel; Guillaume Martin-Blondel
Journal:  Drugs Aging       Date:  2020-11-04       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.